Koios DS
Computer-Assisted Diagnostic Software For Lesions Suspicious For Cancer. 510(k) K242130, from Koios Medical, Inc. (New York, NY). Product code POK, class 2.
As of Nov 20, 2026, K242130 is an FDA 510(k) held by Koios Medical, Inc., substantially equivalent on Nov 15, 2024 after 116 days, with no recalls tied to it in FDA's recall database.
- Review time: 116 days
- Recalls: 0
- Cited as a predicate by: 1 device
Koios Decision Support (DS) is an artificial intelligence (AI)/machine learning (ML)-based computer-aided diagnosis (CADx) software device intended for use as an adjunct to diagnostic ultrasound examinations of lesions or nodules suspicious for breast or thyroid cancer.
- Koios DSK212616 · Koios Medical, Inc. · Dec 16, 2021
- Koios DS for BreastK190442 · Koios Medical, Inc. · Jul 3, 2019
- Koios DS (3.8)K253884 · Koios Medical, Inc. · Jul 2, 2026
- BlineSlideK261679 · Deep Breathe, Inc. · Oct 23, 2026
- Koios DS (3.8)K253884 · Koios Medical, Inc. · Jul 2, 2026
- Sonio SuspectK261519 · Sonio · Jun 4, 2026
- Automated Aortic Stenosis Software (AutoAS)K254161 · GE Medical Systems Ultrasound & Primary Care Diagnostics, LLC · Mar 27, 2026
- RevealAI-LungK251769 · Precision Medical Ventures, Inc. Dba Revealdx · Jan 30, 2026
- Fetal EchoScan (v1.2)K252294 · Brightheart · Dec 8, 2025
- StrokeSENS ASPECTS Software ApplicationK250221 · Circle Cardiovascular Imaging, Inc. · Jul 1, 2025
- Fetal EchoScan (v1.1)K251071 · Brightheart · May 2, 2025
- On FDA's list of AI-enabled devicesFDA AI-enabled medical devices
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jul 22, 2024
- Review panel
- Radiology
- Regulation
- 21 CFR 892.2060
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files